PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies is a research paper published in Trends in Molecular Medicine (2020). On theSindex it has a DataRank of 0.584. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIGMS NIH HHS
Grant: T32 GM007288
NCATS NIH HHS
Grant: TL1 TR002557
NCI NIH HHS
Grant: R01 CA175495
NIDDK NIH HHS
Grant: R01 DK100525
National Institutes of Health
Grant: 2T32GM007288-24
MEDICAL SCIENTIST TRAINING PROGRAM
National Institutes of Health
Grant: 6R01DK100525-05
Mechanisms and Therapies of B7x and B7-H3 in T1D
National Institutes of Health
Grant: 3R01CA175495-09S1
Tumor-expressed immune checkpoint B7x-mediated resistance to anti-CTLA-4 therapy.
National Institutes of Health
Grant: 5TL1TR002557-06
NRSA Training Core
U.S. Department of Defense
National Institutes of Health
FWCI
1.82
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals